Chembio Diagnostics Short Interest Ratio and Short Volume

Short interest is the volume of Chembio Diagnostics shares that have been sold short but have not yet been covered or closed out. As of July 15th, traders have sold 1,280,000 shares of CEMI short. 6.89% of Chembio Diagnostics' shares are currently sold short. Learn More on Chembio Diagnostics' current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.89% of Chembio Diagnostics' floating shares are currently sold short.

Chembio Diagnostics saw a drop in short interest during the month of July. As of July 15th, there was short interest totaling 1,280,000 shares, a drop of 7.9% from the previous total of 1,390,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Chembio Diagnostics currently has issued a total of 20,250,000 shares. Some of Chembio Diagnostics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Chembio Diagnostics currently has a public float of 18,580,000 shares.

6.89% of Chembio Diagnostics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Chembio Diagnostics: Sol-Gel Technologies Ltd. (2.07%), BELLUS Health Inc. (1.82%), Kala Pharmaceuticals, Inc. (14.99%), CTI BioPharma Corp. (2.68%), CorMedix Inc. (6.64%), Pieris Pharmaceuticals, Inc. (5.75%), Trevena, Inc. (11.69%), Spruce Biosciences, Inc. (6.38%), BCTG Acquisition Corp. (0.04%), and Galera Therapeutics, Inc. (2.52%).

As of the most recent reporting period, the following stocks had the largest short interest positions: Advanced Micro Devices, Inc. ($7.55 billion), Square, Inc. ($7.47 billion), S&P Global Inc. ($7.40 billion), Analog Devices, Inc. ($6.82 billion), Aon plc ($5.98 billion), Charter Communications, Inc. ($5.10 billion), Wayfair Inc. ($4.38 billion), AMC Entertainment Holdings, Inc. ($2.87 billion), Teladoc Health, Inc. ($2.55 billion), and Nuance Communications, Inc. ($2.41 billion). View all of the most shorted stocks.

Short selling CEMI is an investing strategy that aims to generate trading profit from Chembio Diagnostics as its price is falling. Chembio Diagnostics' stock is trading up $0.05 today. To short Chembio Diagnostics stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Chembio Diagnostics will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Chembio Diagnostics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CEMI, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CEMI, twice per month. The most recent reporting period available is July, 15 2021.